<unk>  is a Glutamate antagonist that is FDA approved for the treatment of amyotrophic lateral sclerosis (ALS).   Common adverse reactions include headache, abdominal pain, back pain, vomiting, dyspepsia, diarrhea, dizziness.
Riluzole
Lubeluzole
Glatiramer
Suxibuzone
Glatiramer acetate
Fingolimod
Tocilizumab
Bococizumab